e.l.f. Beauty director Maureen Watson sells $445,625 in stock

Published 05/06/2025, 21:26
e.l.f. Beauty director Maureen Watson sells $445,625 in stock

OAKLAND, CA—Maureen C. Watson, a director at e.l.f. Beauty, Inc. (NYSE:ELF), recently executed a significant stock transaction, according to a filing with the Securities and Exchange Commission. On June 3, Watson sold 3,875 shares of e.l.f. Beauty common stock at a price of $115 per share, totaling $445,625. The transaction comes as the company maintains impressive gross profit margins of 71% and has demonstrated strong revenue growth of 28% over the last twelve months.

In addition to the sale, Watson also exercised stock options to acquire 3,875 shares at a price of $1.84 per share, resulting in a total transaction value of $7,130. Following these transactions, Watson holds 1,888 shares of e.l.f. Beauty stock, which includes 1,103 restricted stock units.

These transactions reflect Watson’s ongoing management of her holdings in the company, which is known for its affordable beauty products and has seen significant market activity.

In other recent news, e.l.f. Beauty has been the focus of several analyst updates following its strong fourth-quarter results and strategic moves. Raymond (NSE:RYMD) James raised its price target for e.l.f. Beauty to $130, maintaining a Strong Buy rating, highlighting the company’s growth strategies and the acquisition of Rhode as key factors for future expansion. Truist Securities also increased its price target to $125 from $75, citing revised sales and EBITDA estimates for fiscal years 2026 and 2027, and maintained its Buy rating. Deutsche Bank (ETR:DBKGn) lifted its price target to $96 while holding a Hold rating, noting the positive impact of the Rhode acquisition but expressing caution due to uncertainties in the operating environment.

TD Cowen raised its price target to $130, reiterating a Buy rating, and emphasized the strategic importance of the Rhode acquisition in positioning e.l.f. Beauty as a global beauty platform. Morgan Stanley (NYSE:MS) also adjusted its price target to $105, maintaining an Equalweight rating, following favorable developments related to tariffs and a beneficial court ruling. The acquisition of Rhode for $1 billion is seen as a significant step for e.l.f. Beauty, expected to enhance its market presence and drive growth. Despite some uncertainties, analysts generally express optimism about e.l.f. Beauty’s future prospects, with the company’s strategic initiatives and recent performance drawing positive attention from the investment community.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.